Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Pharmacia Ltd & Upjohn (UK)
Woman Max 99 years
Pharmacia Ltd & Upjohn (UK)
Update Il y a 5 ans
Epirubicin plus tamoxifen versus tamoxifen alone in post-menopausal node positive primary breast cancer
Not provided at time of registration
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman Max 99 years
Pharmacia Ltd & Upjohn (UK)
Update Il y a 5 ans
An adjuvant randomised study comparing standard dose FE[50]C with a higher dose FE[75]C and evaluating the additional benefit of sequential hormone therapy in node positive pre-menopausal primary breast cancer
Not provided at time of registration
Country
None
organs
None
Specialty
None
Closed trial
More information
Pharmacia Ltd & Upjohn (UK)
Update Il y a 5 ans
Randomised phase II study of sequentially high dose Methotrexate and Fluorouracil combined with Epirubicin (FEMTX) versus FEMTX plus Cisplatin (FEMTX-P) in advanced gastric cancer
Not provided at time of registration
Country
United Kingdom
organs
None
Specialty
None
Closed trial
More information
Woman Max 99 years
Pharmacia Ltd & Upjohn (UK)
Update Il y a 5 ans
A Prospective Randomised Comparison of CMF versus Sequential Epirubicin Followed by CMF as Adjuvant Chemotherapy for Women with Early Breast Cancer
http://cancerhelp.cancerresearchuk.org/trials/national-breast-cancer-study-of-epirubicin-as-adjuvant-therapy
Country
United Kingdom
organs
None
Specialty
None
Closed trial
More information
Woman Max 99 years
Pharmacia Ltd & Upjohn (UK)
Update Il y a 5 ans
A randomised double-blind trial in post-menopausal women with primary breast cancer who have received adjuvant tamoxifen for 2-3 years, comparing subsequent adjuvant exemestane treatment with further tamoxifen
Not provided at time of registration
Country
United Kingdom
organs
None
Specialty
None
Closed trial
More information
Woman Max 99 years
Pharmacia Ltd & Upjohn (UK)
Update Il y a 5 ans
Adjuvant cyclophosphamide, methotrexate and 5-Fluorouracil (CMF) versus 5-Fluorouracil, epirubicin and cyclosphosphamide (FEC) in node negative poor-risk primary breast cancer
Not provided at time of registration
Country
None
organs
None
Specialty
None
Closed trial
More information
Pharmacia Ltd & Upjohn (UK)
Update Il y a 5 ans
Phase III Randomised Study of High Dose Methotrexate and 5-Fluouracil Combined with Epirubicin (FEMTX) versus No Treatment in Stage II-III Resected Gastric Cancer
Not provided at time of registration
Country
United Kingdom
organs
None
Specialty
None
Closed trial
More information